AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $66.24
- 52-wk low
- $17.05
- Prev close
- $41.90
- Mkt cap
- $6.22B
- Fwd P/E
- 76.3x
- Beta
- 1.04
Smart money
Earnings
Earnings came in $0.23 a share below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $164.9M | $129.7M | $127.2M | $169.6M |
| Cost of what it sold | $1.6M | $2.6M | $26.8M | $2.2M |
| Gross profit | $163.3M | $127.1M | $100.4M | $167.4M |
| What it spent | ||||
| Research and development | $51.9M | $57.9M | $57.1M | $60.3M |
| Sales and admin | $86.5M | $101.7M | $80.3M | $96.1M |
| Other operating costs | — | — | — | $7.1M |
| Total operating expenses | $138.3M | $159.6M | $137.3M | $163.5M |
| What was left | ||||
| Operating profit | $24.9M | -$32.4M | -$36.9M | $4.0M |
| Interest on debt | $2.8M | $2.3M | $2.3M | $2.1M |
| Profit before tax | $25.7M | -$21.1M | -$36.7M | -$35.0M |
| Tax | $8.0K | $921.0K | -$120.0K | -$204.0K |
| Net profit | $25.7M | $2.7M | -$37.1M | -$34.8M |
| EBITDA | $44.3M | -$632.0K | -$9.2M | -$32.9M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
19 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Travere Therapeutics (NASDAQ: TVTX) director plans 5,000-share sale tied to stock options
NeutralAug 19US High Growth Tech Stocks To Watch In August 2026
BullishAug 18Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline
BullishAug 18
